Annals of Oncology

News:

NDDO splits from EORTC
Ann Oncol 9: 1145-1146.
[PDF] [Request Permissions]

R. Antonini

A successful cancer march
Ann Oncol 9: 1146-1147.
[PDF] [Request Permissions]

American pediatric merger spurns Europe
Ann Oncol 9: 1147.
[PDF] [Request Permissions]

Swiss calculate costs of smoking
Ann Oncol 9: 1147.
[PDF] [Request Permissions]

Wolfgang Hiddemann

Awards, appointments
Ann Oncol 9: 1147-1148.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 9: 1148-1149.
[PDF] [Request Permissions]

Book reviews:

U. Th. Laffer

Book review
Ann Oncol 9: 1150.
[PDF] [Request Permissions]

L. A. Moulopoulos

Book review
Ann Oncol 9: 1250.
[PDF] [Request Permissions]

Editorial:

V. Valero and G. N. Hortobagyi

Primary chemotherapy: A better overall therapeutic option for patients with breast cancer
Ann Oncol 9: 1151-1154.
[PDF] [Request Permissions]

Review:

M. Sasaki and K. H. Plate

Gene therapy of malignant glioma: Recent advances in experimental and clinical studies
Ann Oncol 9: 1155-1166.
[Abstract] [PDF] [Request Permissions]

Review on evidence-based cancer medicine:

N. Neymark

Critical reviews of economic analyses in order to make health care decisions for cancer
Ann Oncol 9: 1167-1172.
[PDF] [Request Permissions]

Arena:

A. Ravaioli, D. Tassinari, G. Pasini, A. Polselli, M. Papi, P. P. Fattori, E. Pasquini, A. Masi, F. Alessandrini, D. Canuti, I. Panzini, and G. Drudi

Staging of breast cancer: What standards should be used in research and clinical practice?
Ann Oncol 9: 1173-1177.
[Abstract] [PDF] [Request Permissions]

Original articles:

A. Makris, T. J. Powles, S. E. Ashley, J. Chang, T. Hickish, V. A. Tidy, A. G. Nash, and H. T. Ford

A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer
Ann Oncol 9: 1179-1184.
[Abstract] [PDF] [Request Permissions]

L. Cagini, A. G. Nicholson, A. Horwich, P. Goldstraw, and U. Pastorino

Thoracic metastasectomy for germ cell tumours: Long term survival and prognostic factors
Ann Oncol 9: 1185-1191.
[Abstract] [PDF] [Request Permissions]

J. F. Vansteenkiste, S. G. Stroobants, P. R. De Leyn, P. J. Dupont, E. K. Verbeken, and The Leuven Lung Cancer Group

Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa–N₂ non-small-cell lung cancer: A prospective pilot study
Ann Oncol 9: 1193-1198.
[Abstract] [PDF] [Request Permissions]

E. Van Cutsem, C. Pozzo, H. Starkhammar, L. Dirix, E. Terzoli, F. Cognetti, Y. Humblet, C. Garufi, L. Filez, G. Gruia, C. Cote, and C. Barone

A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancer
Ann Oncol 9: 1199-1204.
[Abstract] [PDF] [Request Permissions]

S. Joel, K. O'Byrne, R. Penson, D. Papamichael, A. Higgins, H. Robertshaw, R. Rudd, D. Talbot, and M. Slevin

A randomised, concentration-controlled, comparison of standard (5-day) vs. prolonged (15-day) infusions of etoposide phosphate in small-cell lung cancer
Ann Oncol 9: 1205-1211.
[Abstract] [PDF] [Request Permissions]

F. Celsing, S. Widell, K. Merk, P. Bernell, G. Grimfors, A. Hedlund, J. Liliemark, E. Svedmyr, E. Ösby, and M. Björkholm

Addition of etoposide to CHOP chemotherapy in untreated patients with high-grade non-Hodgkin's lymphoma
Ann Oncol 9: 1213-1217.
[Abstract] [PDF] [Request Permissions]

E. Maartense, J. Hermans, J. C. Kluin-Nelemans, P. M. Kluin, W. A. Van Deijk, S. Snijder, P. W. Wijermans, and E. M. Noordijk

Elderly patients with non-Hodgkin's lymphoma: Population-based results in the Netherlands
Ann Oncol 9: 1219-1227.
[Abstract] [PDF] [Request Permissions]

F. Levi, L. Randimbison, and C. La Vecchia

Descriptive epidemiology of vulvar and vaginal cancers in Vaud, Switzerland, 1974–1994
Ann Oncol 9: 1229-1232.
[Abstract] [PDF] [Request Permissions]

R. Stupp, J. Bauer, O. Pagani, B. Gerard, T. Cerny, C. Sessa, G. Bastian, M. Sarkany, J. Schläpfer, B. Giroux, and S. Leyvraz

Ventricular arrhythmia and torsade de pointe: Dose limiting toxicities of the MDR-modulator S9788 in a phase I trial
Ann Oncol 9: 1233-1242.
[Abstract] [PDF] [Request Permissions]

Ph. Van Trappen, R. Serreyn, A. E. Elewaut, V. Cocquyt, and S. Van Belle

Abdominal pain with anorexia in patients with breast carcinoma
Ann Oncol 9: 1243-1245.
[Abstract] [PDF] [Request Permissions]

Short report:

K. A. Gelmon, A. Tolcher, S. O'Reilly, C. Campbell, C. Bryce, T. Shenkier, J. Ragaz, D. Ayers, L. Nakashima, S. Rielly, and H. Dulude

A phase I–II study of bi-weekly paclitaxel as first-line treatment in metastatic breast cancer
Ann Oncol 9: 1247-1249.
[Abstract] [PDF] [Request Permissions]

T. André, C. Louvet, E. Raymond, C. Tournigand, and A. de Gramont

Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen
Ann Oncol 9: 1251-1253.
[Abstract] [PDF] [Request Permissions]

Letters to the editor:

J. Watine

Prognostic impact of an activation of coagulation in lung cancer
Ann Oncol 9: 1255.
[PDF] [Request Permissions]

R. Seitz

This letter was referred to the author, who responds as follows:
Ann Oncol 9: 1255-1256.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.